Jon Faiz Kayyem - 25 May 2023 Form 4 Insider Report for Inhibrx, Inc. (INBX)

Role
Director
Signature
/s/ Kelly D. Deck, attorney-in-fact
Issuer symbol
INBX
Transactions as of
25 May 2023
Transactions value $
$0
Form type
4
Filing time
30 May 2023, 16:07:19 UTC
Previous filing
25 May 2023
Next filing
07 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INBX Stock Option (right to buy) Award $0 +15K $0.00 15K 25 May 2023 Common Stock 15K $23.03 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty-five percent (25%) of the total shares subject to the stock option become exercisable on May 25, 2024, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter.